Literature DB >> 1614067

Effects of calcium antagonists on renal hemodynamics and glomerular function.

P K Carmines1, K D Mitchell, L G Navar.   

Abstract

Cytosolic [Ca2+] can be increased by influx of the ion from the extracellular compartment, Ca2+ release from intracellular storage sites, and/or a reduced activity of active transport processes for Ca2+ extrusion or sequestration. Organic calcium antagonists block transmembrane calcium entry and, therefore, can be utilized to evaluate the importance of calcium influx in the regulation of renal hemodynamics. Recent studies indicate that calcium antagonists selectively vasodilate preglomerular arterioles, leading to increases in renal blood flow (RBF), glomerular filtration rate (GFR) and glomerular pressure. In contrast with angiotensin converting enzyme inhibitors and other vasodilator agents, calcium antagonists primarily influence the component of renal vascular resistance responsible for autoregulation, potently attenuating autoregulatory efficiency. Calcium antagonists also block the afferent arteriolar vasoconstriction elicited by angiotensin II, while not influencing the efferent arteriolar vasoconstriction evoked by this peptide. Tubuloglomerular feedback (TGF)-mediated vasoconstrictor responses are also abolished by calcium antagonists, indicating that the TGF effector mechanism may require transmembrane calcium influx into the smooth muscle cells of the afferent arterioles. These observations provide compelling evidence that calcium influx, through pathways which are influenced by organic calcium antagonists, is an integral component of the afferent arteriolar vasoconstriction elicited by a variety of stimuli, while efferent arteriolar vasoconstriction appears to depend on other calcium access pathways.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1614067

Source DB:  PubMed          Journal:  Kidney Int Suppl        ISSN: 0098-6577            Impact factor:   10.545


  11 in total

1.  Pressure induces intracellular calcium changes in juxtaglomerular cells in perfused afferent arterioles.

Authors:  En Yin Lai; Yibing Wang; Anders Erik Gosta Persson; Roy Davis Manning; Ruisheng Liu
Journal:  Hypertens Res       Date:  2011-06-02       Impact factor: 3.872

2.  No apparent role for T-type Ca²⁺ channels in renal autoregulation.

Authors:  Rasmus Hassing Frandsen; Max Salomonsson; Pernille B L Hansen; Lars J Jensen; Thomas Hartig Braunstein; Niels-Henrik Holstein-Rathlou; Charlotte Mehlin Sorensen
Journal:  Pflugers Arch       Date:  2015-12-14       Impact factor: 3.657

Review 3.  Renal autoregulation in health and disease.

Authors:  Mattias Carlström; Christopher S Wilcox; William J Arendshorst
Journal:  Physiol Rev       Date:  2015-04       Impact factor: 37.312

Review 4.  Physiology of endothelin and the kidney.

Authors:  Donald E Kohan; Edward W Inscho; Donald Wesson; David M Pollock
Journal:  Compr Physiol       Date:  2011-04       Impact factor: 9.090

5.  Contribution of cytochrome P450 epoxygenase and hydroxylase pathways to afferent arteriolar autoregulatory responsiveness.

Authors:  J D Imig; J R Falck; E W Inscho
Journal:  Br J Pharmacol       Date:  1999-07       Impact factor: 8.739

Review 6.  Regulation of blood pressure and salt homeostasis by endothelin.

Authors:  Donald E Kohan; Noreen F Rossi; Edward W Inscho; David M Pollock
Journal:  Physiol Rev       Date:  2011-01       Impact factor: 37.312

7.  Common charge-shift mutation Glu65Lys in K+ channel β₁-Subunit KCNMB1: pleiotropic consequences for glomerular filtration rate and progressive renal disease.

Authors:  Yuqing Chen; Rany M Salem; Fangwen Rao; Maple M Fung; Vibha Bhatnagar; Braj Pandey; Manjula Mahata; Jill Waalen; Caroline M Nievergelt; Michael S Lipkowitz; Bruce A Hamilton; Sushil K Mahata; Daniel T O'Connor
Journal:  Am J Nephrol       Date:  2010-09-23       Impact factor: 3.754

Review 8.  Purinoceptors, renal microvascular function and hypertension.

Authors:  Z Guan; M N Makled; E W Inscho
Journal:  Physiol Res       Date:  2020-04-17       Impact factor: 1.881

9.  Amlodipine and haemodynamic effects of cyclo-oxygenase inhibition.

Authors:  P Minuz; P Pancera; M Ribul; F Priante; M Degan; A Campedelli; E Arosio; A Lechi
Journal:  Br J Clin Pharmacol       Date:  1995-01       Impact factor: 4.335

10.  Rho-kinase inhibition reduces pressure-mediated autoregulatory adjustments in afferent arteriolar diameter.

Authors:  Edward W Inscho; Anthony K Cook; R Clinton Webb; Li-Ming Jin
Journal:  Am J Physiol Renal Physiol       Date:  2009-01-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.